Golden Eye

Golden Eye is an over‑the‑counter ophthalmic preparation containing the active ingredient dibrompropamidine isetionate. It is supplied as a topical ocular solution, with strength not specified on the label, and is marketed in the European Union. Dibrompropamidine isetionate belongs to the antiseptic drug class and disrupts microbial cell membranes, providing bactericidal and fungicidal activity for eye care. It is used to prevent and treat bacterial conjunctivitis and to reduce infection risk after eye procedures.

Golden Eye is indicated for several ophthalmic situations where an antiseptic effect is required.

- Prevention and treatment of bacterial conjunctivitis. - Prophylaxis of ocular infections following surgical procedures such as cataract extraction. - Management of eye trauma where contamination risk exists. - Use as adjunct therapy in cases of mild to moderate keratitis caused by susceptible organisms. - Supportive care for patients with dry eye who are prone to secondary bacterial colonisation. - Short‑term use in contact lens wearers who develop early signs of bacterial irritation.

Adverse reactions to Golden Eye are generally mild and reversible, but rare serious events have been reported.

Common: - Transient stinging or burning sensation upon instillation. - Temporary blurred vision lasting a few minutes. - Mild conjunctival redness or irritation. - Slight tearing or increased lacrimation. - Mild itching of the eyelid margin. - Slight sensation of foreign body. - Temporary increase in intraocular pressure (rare). - Mild photophobia that resolves spontaneously. - Slight swelling of the conjunctiva.

Serious: - Allergic contact dermatitis affecting the eyelids. - Persistent corneal epithelial defect. - Severe ocular inflammation or uveitis. - Development of secondary bacterial infection due to disruption of normal flora. - Vision loss if corneal ulceration develops.

When using Golden Eye, certain precautions should be observed to minimize risk and ensure appropriate therapeutic outcomes.

- Do not use if you have a known hypersensitivity to dibrompropamidine or any component of the formulation. - Avoid contact with the interior of the eye if the solution is cloudy, discolored, or past its expiration date. - Keep the dropper tip clean and do not share the product with others to prevent cross‑contamination. - If symptoms persist beyond 48 hours, discontinue use and seek professional advice. - Use caution in patients with pre‑existing corneal epithelial defects or severe dry eye. - Pregnant or nursing individuals should consult a healthcare professional before use, as safety data are limited.

Golden Eye may interact with other ophthalmic products or systemic medications; consider the following guidance.

Avoid: - Concurrent use with other antimicrobial eye drops containing chlorhexidine or povidone‑iodine, as additive toxicity may increase ocular irritation. - Mixing Golden Eye with intra‑ocular injections or implants, which could alter drug distribution.

Use with caution: - Use with caution when administering topical corticosteroids, as the combined effect may mask signs of infection. - Caution is advised when using preservative‑containing artificial tears, which could affect tolerability. - If systemic antibiotics are being taken, monitor for potential changes in ocular flora, although direct interaction is unlikely.